Status:
COMPLETED
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
Lead Sponsor:
Loma Linda University
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine hypofractionated conformal proton beam radiation therapy of prostate cancer can achieve similar treatment benefits as our current institutional standard with ...
Detailed Description
Radiation therapy has a long and established role in the curative treatment of organ-confined prostate cancer. However, the optimal radiation dose and treatment schedule remain unknown. The use of hyp...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma within 180 days of registration
- History \& Physical Exam, including digital rectal exam (DRE), within 8 wks prior to registration
- Histologic evaluation of prostate biopsies at LLUMC, with Gleason score assignment
- Clinical stage, Tumor Stage (T1-T2C)
- Prostatic Specific Antigen (PSA) less than 10 ng.ml within 180 days prior to registration
Exclusion
- Prior or concurrent invasive malignancy
- Evidence of distant metastasis
Key Trial Info
Start Date :
February 17 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 18 2019
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT00831623
Start Date
February 17 2009
End Date
July 18 2019
Last Update
March 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University Medical Center / James M. Slater Proton Treatment Center
Loma Linda, California, United States, 92354